DOCSLIB.ORG

Engineering the Genome of Minimal Bacteria Using CRISPR/Cas9 Tools Iason Tsarmpopoulos

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Engineering the genome of minimal bacteria using CRISPR/Cas9 tools Iason Tsarmpopoulos To cite this version: Iason Tsarmpopoulos. Engineering the genome of minimal bacteria using CRISPR/Cas9 tools. Mi- crobiology and Parasitology. Université de Bordeaux, 2017. English. NNT : 2017BORD0787. tel- 01834971 HAL Id: tel-01834971 https://tel.archives-ouvertes.fr/tel-01834971 Submitted on 11 Jul 2018 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. THÈSE PRÉSENTÉE POUR OBTENIR LE GRADE DE DOCTEUR DE L’UNIVERSITÉ DE BORDEAUX ÉCOLE DOCTORALE Science de la vie et de la Santé SPÉCIALITÉ Microbiologie and Immunologie Par Iason TSARMPOPOULOS Ingénierie de génome de bactéries minimales par des outils CRISPR/Cas9 Sous la direction de : Monsieur Pascal SIRAND-PUGNET Soutenue le jeudi 07 décembre 2017 à 14h00 Lieu : INRA, 71 avenue Edouard Bourlaux 33882 Villenave d'Ornon salle Amphithéâtre Josy et Colette Bové Membres du jury : Mme Cécile BEBEAR Université de Bordeaux et CHU de Bordeaux Président Mme Florence TARDY Anses-Laboratoire de Lyon Rapporteur M. Matthieu JULES Institut Micalis, INRA and AgroParisTech Rapporteur M. David BIKARD Institut Pasteur Examinateur M. Fabien DARFEUILLE INSERM U1212 - CNRS UMR 5320 Invité Mme Carole LARTIGUE-PRAT INRA - Université de Bordeaux Invité M. Pascal SIRAND-PUGNET Université de Bordeaux Directeur de thèse Ingénierie de génome de bactéries minimales par des outils CRISPR/Cas9 Les mycoplasmes sont des bactéries pathogènes, dotées de petits génomes d’environ 1Mbp, avec une faible teneur en G+C. L'intérêt de la communauté scientifique pour ces bactéries a été récemment renouvelé par des avancées dans les domaines de la synthèse et de la transplantation de génomes. Ces nouvelles approches ont ouvert la voie à l'ingénierie génomique à grande échelle des mycoplasmes. Les systèmes CRISPR/Cas sont des systèmes de défense adaptatifs procaryotes contre les acides nucléiques invasifs. Le système CRISPR de Streptococcus pyogenes est composé d’une endonucléase (SpCas9) et de deux CRISPR ARNs (crRNA et tracrRNA) qui dirigent Cas9 vers sa séquence d’ADN cible. La reconnaissance de l’ADN cible se fait par appariement du crRNA et de la présence en aval d’une séquence nommée protospacer adjacent motif (PAM). Apres cette reconnaissance, Cas9 coupe l’ADN cible. A partir de ce système, un outil génétique simplifié composé de Cas9 et d’un ARN guide (gRNA) a été développé pour de nombreux organismes. Le premier objectif de ma thèse était de combiner les méthodes de biologie synthétique de clonage et de la transplantation de génomes avec les outils CRISPR/Cas9 pour l’ingénierie des génomes de mycoplasmes clonés dans la levure. Nous avons réussi à utiliser cette approche pour enlever des gènes et des régions génomiques dans trois espèces: Mycoplasma mycoides subsp. capri (Mmc), M. capricolum subsp. capricolum et M. pneumoniae. Afin de développer un système plus adapté aux mycoplasmes, nous avons ensuite caractérisé le système CRISPR/Cas9 de Mycoplasma gallisepticum (Mg). En utilisant une combinaison d'approches in silico et in vivo, la séquence PAM de MgCas9 a été caractérisée comme NNNAAAA. Nous avons alors entrepris de développer un système CRISPR/Cas minimal de M. gallisepticum pour une utilisation directe dans les cellules de mollicutes: le gène codant MgCas9 a été introduit dans le génome de Mmc, mais son activation avec un gRNA chimère entre le crRNA et le tracrRNA de M. gallisepticum n’a pas été obtenue pour le moment. Mots clés : Biologie de synthèse, CRISPR/Cas9, Mycoplasma Engineering the genome of minimal bacteria using CRISPR/Cas9 tools Mycoplasmas are small pathogenic bacteria that are characterized by reduced genomes of about 1 Mbp with a low G+C content. The interest of the scientific community towards these species has been recently renewed by successful synthesis of their genome and transplantation experiments. These new genetic tools opened the way to further applications and developments for large-scale genome engineering programmes. CRISPR/Cas systems are natural systems that provide bacteria and archaea with an adaptive defense mechanism against invading nucleic acids. The CRISPR system from Streptococcus pyogenes includes an endonuclease (SpCas9) and two CRISPR RNAs (crRNA et tracrRNA) which role are to drive Cas9 to a target sequence. Target recognition depends on a specific pairing of the crRNA and the presence of a motif named protospacer adjacent motif (PAM). After recognition, Cas9 cleaves the targeted DNA. From the natural S. pyogenes system, a simplified genetic tool including Cas9 and a guide RNA (gRNA) was developed for many organisms . The first goal of my thesis was to combine the synthetic biology methods of genome cloning in yeast and back transplantation into recipient cells with a CRISPR/Cas9 tool for efficient engineering of mycoplasma genomes cloned in yeast. We succeeded in removing genes and genomic regions in three different species, Mycoplasma mycoides subsp. capri (Mmc), M. capricolum subsp. capricolum and M. pneumoniae. Then, in order to develop a system optimized for mycoplasma genome editing, we characterized a natural CRISPR/Cas9 system derived from Mycoplasma gallisepticum (Mg). Using a combination of in silico and in vivo approaches, MgCas9 PAM sequence was characterized as NNNAAAA. We then started to develop a minimal CRISPR/Cas system from M. gallisepticum for direct genome editing in mollicutes. Thus we introduced MgCas9 encoding gene in Mmc and tried to activate it with a newly designed gRNA, a chimeric molecule between the crRNA and the tracrRNA of M. gallisepticum, without success yet. Keywords : Synthetic Biology, CRISPR/Cas9, Mycoplasma UMR 1332 Biologie du Fruit et Pathologie INRA, IBVM, 71 Av. E. Bourlaux, CS 20032 33882 Villenave d'Ornon Cedex, France Table of contents Acronym List p.1 Introduction p.2 I. Mollicutes p.2 II. Taxonomy and Phylogeny p.3 a. Taxonomy p.3 b. Phylogeny p.4 III. Evolution and structure of mollicutes genome p.4 i. Evolution with genome reduction p.4 ii. Synteny loss p.5 iii. Impact of horizontal gene transfer p.5 iv. HGT in mollicutes p.6 1. Between human pathogens p.6 2. Between bird pathogens p.6 3. Between ruminant pathogen p.7 IV. Mollicutes mobile elements p.8 a. Insertion sequences p.8 b. Integrative and conjugative elements p.8 c. Plasmids in Mollicutes p.10 d. Phages p.10 e. Mobile element control p.11 Restriction-modification systems p.11 Abortive infection mechanisms and Bacteriophages Exclusion system p.12 CRISPR/Cas systems p.12 V. Pathogenicity and disease control p.12 VI. Genome engineering of mollicutes p.16 a. Random mutagenesis using transposons p.16 b. Directed mutagenesis p.17 i. Directed mutagenesis using suicide plasmids p.18 ii. Directed mutagenesis using oriC plasmids p.18 c. Synthetic biology applications p.19 i. Cloning natural or synthetic genomes of mycoplasma in yeast p.19 ii. Genome transplantation as a key process to get a living bacterium p.20 iii. Tools for genome engineering of bacterial genome cloned in yeast p.21 VII. CRISPR/Cas system p.22 a. Natural prokaryotic system p.22 b. Functional characterization of the CRISPR system p.23 c. CRISPR as a gene regulation mechanism p.24 d. Universal tool for genome manipulation p.24 e. Development of CRISPR/Cas system as an editing tool for bacterial p.26 Objectives of thesis p.27 Results Chapter 1: Adaptation of the CRISPR/Cas9 of Streptococcus pyogenes for manipulation of mycoplasma genome already transformed in yeast p.28 A. Strategy p.28 B. Application of CRISPR/Cas9 for genome editing in Saccharomyces cerevisiae p.29 C. Proof of concept: Replacement of glpO gene with a marker in Mmc p.29 D. Evaluation of the CRISPR/Cas9 tool for in-yeast engineering of different mycoplasma species p.32 a. M. capricolum subsp. capricolum: precise deletions within the MCAP0015- MCS2-MCAP0017 locus p.32 b. M. pneumoniae: deletion of a virulence factor (MPN142) p.33 Discussion p.34 Chapter 2: Characterization of the native CRISPR/Cas9 system of M. gallisepticum p.36 Comparative genomics of CRISPR in mollicutes p.36 1. Distribution of CRISPR system in mollicutes p.36 2. Phylogenomics of mollicutes CRISPR systems p.37 3. Direct Repeats and tracrRNA p.38 4. CRISPR of M. gallisepticum p.39 5. In silico prediction of PAM sequence p.40 o Development of a dedicated “R” script p.40 o Particular case of spacer 12 of M. gallisepticum R low and R high strains p.41 o Extra Candidates collection p.41 6. In vivo evaluation of PAM candidates and CRISPR/Cas9 system activity in M. gallisepticum p.42 o One and two plasmids strategies p.42 o Determination of PAM consensus sequence p.44 Discussion p.45 Chapter 3. M. gallisepticum CRISPR system as a tool for targeted cleavage in mollicutes p.47 o Introduction of a MgCas9 gene in the Mmc genome p.47 o Construction of a hybrid gRNA from Mgal CRISPR p.48 o Evaluation of the MgCas9/gRNA tool in Mmc p.49 o Transformation of the MmcCas9ICE cells with the gRNA p.49 Discussion p.49 General Discussion p.51 Chapter 1 p.51 Chapter 2 p.53 Chapter 3 p.56 Materials and Methods p.59 Abbreviation list A, C, G, T, U = Adenine, Cytosine, Guanine, Thymine, Uracil Cas proteins = CRISPR associated proteins CDS = Coding DNA Sequence CRISPR = Clustered Regularly Interspaced Short Palindromic Repeats crRNA = Crispr RNA DNA = Deoxyribo-Nucleic Acid DR = Direct Repeat DSB(s) = Double strand Break(s) glpO = glycerol-3-phosphate oxidase gRNA = guide RNA HCO = Hexaammine-CObalt HDR = Homologous Directed Repair HGT = Horizontal Gene Transfer ICE = Integrative and Conjugative Element Mcap = Mycoplasma capricolum subsp.
Recommended publications
  • The Role of Earthworm Gut-Associated Microorganisms in the Fate of Prions in Soil

    The Role of Earthworm Gut-Associated Microorganisms in the Fate of Prions in Soil

    THE ROLE OF EARTHWORM GUT-ASSOCIATED MICROORGANISMS IN THE FATE OF PRIONS IN SOIL Von der Fakultät für Lebenswissenschaften der Technischen Universität Carolo-Wilhelmina zu Braunschweig zur Erlangung des Grades eines Doktors der Naturwissenschaften (Dr. rer. nat.) genehmigte D i s s e r t a t i o n von Taras Jur’evič Nechitaylo aus Krasnodar, Russland 2 Acknowledgement I would like to thank Prof. Dr. Kenneth N. Timmis for his guidance in the work and help. I thank Peter N. Golyshin for patience and strong support on this way. Many thanks to my other colleagues, which also taught me and made the life in the lab and studies easy: Manuel Ferrer, Alex Neef, Angelika Arnscheidt, Olga Golyshina, Tanja Chernikova, Christoph Gertler, Agnes Waliczek, Britta Scheithauer, Julia Sabirova, Oleg Kotsurbenko, and other wonderful labmates. I am also grateful to Michail Yakimov and Vitor Martins dos Santos for useful discussions and suggestions. I am very obliged to my family: my parents and my brother, my parents on low and of course to my wife, which made all of their best to support me. 3 Summary.....................................................………………………………………………... 5 1. Introduction...........................................................................................................……... 7 Prion diseases: early hypotheses...………...………………..........…......…......……….. 7 The basics of the prion concept………………………………………………….……... 8 Putative prion dissemination pathways………………………………………….……... 10 Earthworms: a putative factor of the dissemination of TSE infectivity in soil?.………. 11 Objectives of the study…………………………………………………………………. 16 2. Materials and Methods.............................…......................................................……….. 17 2.1 Sampling and general experimental design..................................................………. 17 2.2 Fluorescence in situ Hybridization (FISH)………..……………………….………. 18 2.2.1 FISH with soil, intestine, and casts samples…………………………….……... 18 Isolation of cells from environmental samples…………………………….……….
  • Margaret A. Highland, DVM Washington State University

    Margaret A. Highland, DVM Washington State University

    Bacterial Pneumonia in Sheep, The Domestic – Bighorn Sheep Interface, and Research at ADRU USAHA Committee on Sheep and Goats Providence, RI October 27, 2015 PLC M. A. Highland, DVM, DACVP, PhD candidate PhD Veterinary Training Program USDA-ARS ADRU Veterinary Microbiology and Pathology Washington State University Pullman, WA DS – BHS Interface Issue Captive/penned commingling studies & anecdotal field reports associate BHS and DS contact with BHS pneumonia Removal of DS public land grazing allotments - profound economic impacts Pneumonia continues to afflict BHS herds - despite decades of research and intense management practices Anecdotal field reports also associate DG with BHS pneumonia - pack goat restrictions on public lands DS and BHS Pneumonia DS . Lambs > Adults . Etiology • Polymicrobial (bacteria +/- viruses) or Unimicrobial • Multifactorial (colostrum, air quality, environmental stressors) BHS (wild) . Reports of respiratory disease date back to the 1920’s . All age outbreaks +/- subsequent years of disease in lambs → population-limiting disease . Etiology • Long been debated • Evidence for polymicrobial (bacterial) and multifactorial • Viruses occasionally reported (no current indication for primary role) What do we know about BHS (and DS) pneumonia? Polymicrobial and Multifactorial (the presence of the bacteria in BHS alone does NOT = disease/death) Incompletely understood disease phenomenon DS and BHS pneumonia-associated bacteria Mycoplasma ovipneumoniae (M ovi) Pasteurellaceae (“Pasteurellas”) . Mannheimia haemolytica
  • Role of Protein Phosphorylation in Mycoplasma Pneumoniae

    Role of Protein Phosphorylation in Mycoplasma Pneumoniae

    Pathogenicity of a minimal organism: Role of protein phosphorylation in Mycoplasma pneumoniae Dissertation zur Erlangung des mathematisch-naturwissenschaftlichen Doktorgrades „Doctor rerum naturalium“ der Georg-August-Universität Göttingen vorgelegt von Sebastian Schmidl aus Bad Hersfeld Göttingen 2010 Mitglieder des Betreuungsausschusses: Referent: Prof. Dr. Jörg Stülke Koreferent: PD Dr. Michael Hoppert Tag der mündlichen Prüfung: 02.11.2010 “Everything should be made as simple as possible, but not simpler.” (Albert Einstein) Danksagung Zunächst möchte ich mich bei Prof. Dr. Jörg Stülke für die Ermöglichung dieser Doktorarbeit bedanken. Nicht zuletzt durch seine freundliche und engagierte Betreuung hat mir die Zeit viel Freude bereitet. Des Weiteren hat er mir alle Freiheiten zur Verwirklichung meiner eigenen Ideen gelassen, was ich sehr zu schätzen weiß. Für die Übernahme des Korreferates danke ich PD Dr. Michael Hoppert sowie Prof. Dr. Heinz Neumann, PD Dr. Boris Görke, PD Dr. Rolf Daniel und Prof. Dr. Botho Bowien für das Mitwirken im Thesis-Komitee. Der Studienstiftung des deutschen Volkes gilt ein besonderer Dank für die finanzielle Unterstützung dieser Arbeit, durch die es mir unter anderem auch möglich war, an Tagungen in fernen Ländern teilzunehmen. Prof. Dr. Michael Hecker und der Gruppe von Dr. Dörte Becher (Universität Greifswald) danke ich für die freundliche Zusammenarbeit bei der Durchführung von zahlreichen Proteomics-Experimenten. Ein ganz besonderer Dank geht dabei an Katrin Gronau, die mich in die Feinheiten der 2D-Gelelektrophorese eingeführt hat. Außerdem möchte ich mich bei Andreas Otto für die zahlreichen Proteinidentifikationen in den letzten Monaten bedanken. Nicht zu vergessen ist auch meine zweite Außenstelle an der Universität in Barcelona. Dr. Maria Lluch-Senar und Dr.
  • Genome Published Outside of SIGS, January – June 2011 Methylovorus Sp

    Genome Published Outside of SIGS, January – June 2011 Methylovorus Sp

    Standards in Genomic Sciences (2011) 4:402-417 DOI:10.4056/sigs.2044675 Genome sequences published outside of Standards in Genomic Sciences, January – June 2011 Oranmiyan W. Nelson1 and George M. Garrity1 1Editorial Office, Standards in Genomic Sciences and Department of Microbiology, Michigan State University, East Lansing, MI, USA The purpose of this table is to provide the community with a citable record of publications of on- going genome sequencing projects that have led to a publication in the scientific literature. While our goal is to make the list complete, there is no guarantee that we may have omitted one or more publications appearing in this time frame. Readers and authors who wish to have publica- tions added to this subsequent versions of this list are invited to provide the bibliometric data for such references to the SIGS editorial office. Phylum Crenarchaeota “Metallosphaera cuprina” Ar-4, sequence accession CP002656 [1] Thermoproteus uzoniensis 768-20, sequence accession CP002590 [2] “Vulcanisaeta moutnovskia” 768-28, sequence accession CP002529 [3] Phylum Euryarchaeota Methanosaeta concilii, sequence accession CP002565 (chromosome), CP002566 (plasmid) [4] Pyrococcus sp. NA2, sequence accession CP002670 [5] Thermococcus barophilus MP, sequence accession CP002372 (chromosome) and CP002373 plasmid) [6] Phylum Chloroflexi Oscillochloris trichoides DG-6, sequence accession ADVR00000000 [7] Phylum Proteobacteria Achromobacter xylosoxidans A8, sequence accession CP002287 (chromosome), CP002288 (plasmid pA81), and CP002289
  • Examining the Risk of Disease Transmission Between Wild Dall's

    Examining the Risk of Disease Transmission Between Wild Dall's

    Examining the Risk of Disease Transmission between Wild Dall’s Sheep and Mountain Goats, and Introduced Domestic Sheep, Goats, and Llamas in the Northwest Territories Prepared for: The Northwest Territories Agricultural Policy Framework and Environment and Natural Resources Government of the Northwest Territories, Canada August 20, 2005 Examining the Risk of Disease Transmission between Wild Dall’s Sheep and Mountain Goats, and Introduced Domestic Sheep, Goats, and Llamas in the Northwest Territories Elena Garde 1,2 , Susan Kutz 1,3 , Helen Schwantje 4, Alasdair Veitch 5, Emily Jenkins 1,6 , Brett Elkin 7 1 Research Group for Arctic Parasitology and the Canadian Cooperative Wildlife Health Centre, Western College of Veterinary Medicine, University of Saskatchewan, 52 Campus Drive, Saskatoon, SK, S7N 5B4. 2 Associate Wildlife Veterinarian, Biodiversity Branch, Ministry of Environment, PO Box 9338, Stn Prov Govt, 2975 Jutland Road, Victoria, BC, V8W 9M1, (250) 953-4285 [email protected] 3 Associate Professor, Faculty of Veterinary Medicine, University of Calgary, 3330 Hospital Dr. NW, Calgary AB, T2N 4N1 Ph: (306) 229-6110 4 Wildlife Veterinarian, Biodiversity Branch, Ministry of Environment, PO Box 9338, Stn Prov Govt, 2975 Jutland Road, Victoria, BC, V8W 9M1, (250) 953-4285 [email protected] 5 Supervisor, Wildlife Management, Environment and Natural Resources, Sahtu Region, P.O. Box 130, Norman Wells, NT X0E 0V0, Ph: (867) 587-2786; Fax: (867) 587-2359 [email protected] 6 Wildlife Disease Specialist / Research Scientist, Canadian Wildlife Service, 115 Perimeter Rd. Saskatoon, SK S7N 0X4 (306) 975-5357, (306) 966-7246 7 Disease & Contaminants Specialist, Environment and Natural Resources, 500 – 6102 50 th Ave.
  • Genomes Published Outside of SIGS, June

    Genomes Published Outside of SIGS, June

    Standards in Genomic Sciences (2011) 5:154-167 DOI:10.4056/sigs.2324675 Genome sequences of Bacteria and Archaea published outside of Standards in Genomic Sciences, June – September 2011 Oranmiyan W. Nelson1 and George M. Garrity1 1Editorial Office, Standards in Genomic Sciences and Department of Microbiology, Michigan State University, East Lansing, MI, USA The purpose of this table is to provide the community with a citable record of publications of ongoing genome sequencing projects that have led to a publication in the scientific literature. While our goal is to make the list complete, there is no guarantee that we may have omitted one or more publications appearing in this time frame. Readers and authors who wish to have publications added to this subsequent versions of this list are invited to provide the bib- liometric data for such references to the SIGS editorial office. Phylum Crenarchaeota Phylum Euryarchaeota Pyrococcus yayanosii CH1, sequence accession CP002779 [1] Methanocella paludicola, sequence accession AP011532 [2] Halorhabdus tiamatea, sequence accession AFNT00000000 [3] Thermococcus sp. Strain 4557, sequence accession CP002920 [4] Phylum Chloroflexi Phylum Proteobacteria Ralstonia solanacearum strain Po82, sequence accession CP002819 (chromosome) and CP002820 (megaplasmid) [5 Desulfovibrio alaskensis G20, sequence accession CP000112 [6] Methylophaga aminisulfidivorans MPT, sequence accession AFIG00000000 [7] Acinetobacter sp. P8-3-8, sequence accession AFIE00000000 [8] Sphingomonas strain KC8, sequence accession AFMP01000000
  • A Pilot Study of the Effects of Mycoplasma Ovipneumoniae Exposure on Domestic Lamb Growth And

    A Pilot Study of the Effects of Mycoplasma Ovipneumoniae Exposure on Domestic Lamb Growth And

    bioRxiv preprint doi: https://doi.org/10.1101/459628; this version posted November 1, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Full title: 2 A pilot study of the effects of Mycoplasma ovipneumoniae exposure on domestic lamb growth and 3 performance. 4 5 Thomas E. Besser1*, Jessica Levy1, Melissa Ackerman2, Danielle Nelson1, Kezia Manlove3, Kathleen A. 6 Potter1, Jan Busboom4, Margaret Benson4 7 8 Short title: 9 Sub-clinical Mycoplasma ovipneumoniae infection 10 11 1 Department of Veterinary Microbiology and Pathology, Washington State University College of 12 Veterinary Medicine, Pullman WA, United States of America 13 2 Department of Veterinary Clinical Sciences, Washington State University College of Veterinary 14 Medicine, Pullman WA, United States of America 15 3 Department of Wildland Resources, Utah State University College of Natural Resources, Logan UT, 16 United States of America 17 4 Department of Animal Sciences, Washington State University College of Agricultural, Human, and 18 Natural Resource Sciences, Pullman WA, United States of America. 19 * Corresponding author 20 E-mail: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/459628; this version posted November 1, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license.
  • Mycoplasma Ovipneumoniae Rotter ML, Hirschl AM

    Mycoplasma Ovipneumoniae Rotter ML, Hirschl AM

    RESEARCH LETTERS Figure. Direct examination with dark-field microscopy of specimens from a patient with agammaglobulinemia who had Spiroplasma apis infection, France. A) Helical and motile bacteria in blood culture. B) Elongated and coccoid bacteria in joint fluid. C) Helical and motile bacteria in culture from joint fluid in modified SP4 broth medium. Scale bar indicates 10 µm. than honeybees. The insect stings in this patient are a likely 7. Mueller NJ, Tini GM, Weber A, Gaspert A, Husmann L, gateway of the reported infection. Bloemberg G, et al. Hepatitis from Spiroplasma sp. in an immunocompromised patient. Am J Transplant. 2015;15:2511–6. In summary, clinicians and microbiologists should be http://dx.doi.org/10.1111/ajt.13254 aware of fastidious organisms in atypical infections in im- 8. Lorenz B, Schroeder J, Reischl U. First evidence of an endogenous munocompromised patients. Our findings indicate a need Spiroplasma sp. infection in humans manifesting as unilateral for prolonged culture on specific agar on all joint fluids in cataract associated with anterior uveitis in a premature baby. Graefes Arch Clin Exp Ophthalmol. 2002;240:348–53. patients with agammaglobulinemia and targeted molecular http://dx.doi.org/10.1007/s00417-002-0453-3 methods to identify S. apis organisms. 9. Aquilino A, Masiá M, López P, Galiana AJ, Tovar J, Andrés M, et al. First human systemic infection caused by Spiroplasma. J Clin Microbiol. 2015;53:719–21. http://dx.doi.org/10.1128/JCM.02841-14 Acknowledgments We thank Anne Laurence Thomi Georgelin, who referred the Address for correspondence: Olivier Lortholary, Necker-Enfants Malades patient to the Necker-Pasteur Center for Infectious Diseases and University Hospital, 149 rue de Sevre 75743, Paris CEDEX, France; Tropical Medicine; Valérie Zeller for the management of septic email: [email protected] polyarthritis; and Philippe Lanotte and Marie-Pierre Dubrana, who participated in molecular analysis.
  • Attachment 1 .PLOS ONE

    Attachment 1 .PLOS ONE

    Attachment 1 .PLOS ONE CORRECTION Correction: Exposure of bighorn sheep to domestic goats colonized with Mycoplasma ovipneumoniae induces sub-lethal pneumonia Thomas E. Besser, E. Frances Cassirer, Kathleen A. Potter, William J. Foreyt Tn response to queries raised after publication, the authors, the authors’ institution (Office of Research Assurance, Washington State University) and a member of PLOS ONE’s Editorial Board have reviewed the findings in this article, and as a consequence the authors provide an update to the Competing Interests statement and clarifications regarding the results: The competing interests declaration is updated to acknowledge additional sources of fund ing received by the authors. This specific study was supported by funding competitively awarded by the Wild Sheep Foundation and by revenue from the WSU Rocky Crate Endow ment for Wild Sheep Disease Research. Additional research funding for the authors’ bighorn sheep pneumonia-related research has been received from the US Department of Agriculture (including the Animal Plant Health Inspection Service and the US Forest Service), the US Geo logic Survey, numerous chapters and affiliates of the Wild Sheep Foundation, and the WSU Fowler Emerging Infectious Diseases endowment. Regarding the pneumonia diagnosis reported in the article, the authors re-assessed the pri mary data and solicited and received a second opinion from a veterinary pathologist at Wash ington Animal Disease Diagnostic Lab (WADDL) unassociated with the original project. Following this reassessment, the authors confirmed the descriptions and diagnoses as reported in the article, but they noted that the consulted pathologist advised, “some pathologists might describe the histopathologic lesions seen in the least severely affected animal as ‘bronchiolitis’ rather than ‘pneumonia’ due to the preponderance of that lesion in that animal”.
  • ( 12 ) United States Patent

    ( 12 ) United States Patent

    US009956282B2 (12 ) United States Patent ( 10 ) Patent No. : US 9 ,956 , 282 B2 Cook et al. (45 ) Date of Patent: May 1 , 2018 ( 54 ) BACTERIAL COMPOSITIONS AND (58 ) Field of Classification Search METHODS OF USE THEREOF FOR None TREATMENT OF IMMUNE SYSTEM See application file for complete search history . DISORDERS ( 56 ) References Cited (71 ) Applicant : Seres Therapeutics , Inc. , Cambridge , U . S . PATENT DOCUMENTS MA (US ) 3 ,009 , 864 A 11 / 1961 Gordon - Aldterton et al . 3 , 228 , 838 A 1 / 1966 Rinfret (72 ) Inventors : David N . Cook , Brooklyn , NY (US ) ; 3 ,608 ,030 A 11/ 1971 Grant David Arthur Berry , Brookline, MA 4 ,077 , 227 A 3 / 1978 Larson 4 ,205 , 132 A 5 / 1980 Sandine (US ) ; Geoffrey von Maltzahn , Boston , 4 ,655 , 047 A 4 / 1987 Temple MA (US ) ; Matthew R . Henn , 4 ,689 ,226 A 8 / 1987 Nurmi Somerville , MA (US ) ; Han Zhang , 4 ,839 , 281 A 6 / 1989 Gorbach et al. Oakton , VA (US ); Brian Goodman , 5 , 196 , 205 A 3 / 1993 Borody 5 , 425 , 951 A 6 / 1995 Goodrich Boston , MA (US ) 5 ,436 , 002 A 7 / 1995 Payne 5 ,443 , 826 A 8 / 1995 Borody ( 73 ) Assignee : Seres Therapeutics , Inc. , Cambridge , 5 ,599 ,795 A 2 / 1997 McCann 5 . 648 , 206 A 7 / 1997 Goodrich MA (US ) 5 , 951 , 977 A 9 / 1999 Nisbet et al. 5 , 965 , 128 A 10 / 1999 Doyle et al. ( * ) Notice : Subject to any disclaimer , the term of this 6 ,589 , 771 B1 7 /2003 Marshall patent is extended or adjusted under 35 6 , 645 , 530 B1 . 11 /2003 Borody U .
  • Genetic Profiling of Mycoplasma Hyopneumoniae Melissa L

    Genetic Profiling of Mycoplasma Hyopneumoniae Melissa L

    Iowa State University Capstones, Theses and Retrospective Theses and Dissertations Dissertations 2005 Genetic profiling of Mycoplasma hyopneumoniae Melissa L. Madsen Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/rtd Part of the Microbiology Commons, Molecular Biology Commons, and the Veterinary Medicine Commons Recommended Citation Madsen, Melissa L., "Genetic profiling of Mycoplasma hyopneumoniae " (2005). Retrospective Theses and Dissertations. 1793. https://lib.dr.iastate.edu/rtd/1793 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. NOTE TO USERS This reproduction is the best copy available. ® UMI Genetic profiling of Mycoplasma hyopneumoniae by Melissa L. Madsen A dissertation submitted to the graduate faculty in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Major: Molecular, Cellular and Developmental Biology Program of Study Committee: F. Chris Minion, Major Professor Daniel S. Nettleton Gregory J. Phillips Eileen L. Thacker Eve Wurtele Iowa State University Ames, Iowa 2005 UMI Number: 3200480 INFORMATION TO USERS The quality of this reproduction is dependent upon the quality of the copy submitted. Broken or indistinct print, colored or poor quality illustrations and photographs, print bleed-through, substandard margins, and improper alignment can adversely affect reproduction. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted.
  • Effectors of Mycoplasmal Virulence 1 2 Virulence Effectors of Pathogenic Mycoplasmas 3 4 Meghan A. May1 And

    Effectors of Mycoplasmal Virulence 1 2 Virulence Effectors of Pathogenic Mycoplasmas 3 4 Meghan A. May1 And

    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 27 September 2018 doi:10.20944/preprints201809.0533.v1 1 Running title: Effectors of mycoplasmal virulence 2 3 Virulence Effectors of Pathogenic Mycoplasmas 4 5 Meghan A. May1 and Daniel R. Brown2 6 7 1Department of Biomedical Sciences, College of Osteopathic Medicine, University of New 8 England, Biddeford ME, USA; 2Department of Infectious Diseases and Immunology, College 9 of Veterinary Medicine, University of Florida, Gainesville FL, USA 10 11 Corresponding author: 12 Daniel R. Brown 13 Department of Infectious Diseases and Immunology, College of Veterinary Medicine, 14 University of Florida, Gainesville FL, USA 15 Tel: +1 352 294 4004 16 Email: [email protected] 1 © 2018 by the author(s). Distributed under a Creative Commons CC BY license. Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 27 September 2018 doi:10.20944/preprints201809.0533.v1 17 Abstract 18 Members of the genus Mycoplasma and related organisms impose a substantial burden of 19 infectious diseases on humans and animals, but the last comprehensive review of 20 mycoplasmal pathogenicity was published 20 years ago. Post-genomic analyses have now 21 begun to support the discovery and detailed molecular biological characterization of a 22 number of specific mycoplasmal virulence factors. This review covers three categories of 23 defined mycoplasmal virulence effectors: 1) specific macromolecules including the 24 superantigen MAM, the ADP-ribosylating CARDS toxin, sialidase, cytotoxic nucleases, cell- 25 activating diacylated lipopeptides, and phosphocholine-containing glycoglycerolipids; 2) 26 the small molecule effectors hydrogen peroxide, hydrogen sulfide, and ammonia; and 3) 27 several putative mycoplasmal orthologs of virulence effectors documented in other 28 bacteria.